Ss-31
Educational resource. Not medical advice. No dosing or instructions.
Why people are interested in this peptide and how it is commonly discussed in real-world wellness, rehabilitation, and athletic communities.
- sS-31 (elamipretide) is a mitochondria-targeting peptide that binds cardiolipin and is studied for improving mitochondrial function
- an educational summary; see evidence links
- general recovery and resilience interest (anecdotal)
- common biohacker curiosity due to community reports
- interest in mechanisms suggested by early evidence
- used in goal-based stacking discussions (anecdotal)
- exploration in wellness communities despite evidence limits
SS-31 (elamipretide) is a mitochondria-targeting peptide studied in clinical research for mitochondrial dysfunction-related conditions. In wellness communities it is discussed for fatigue and recovery, but the evidence base is specialized and product quality differences are a major practical risk.
Common reasons people consider it
- Energy and fatigue support interest in some communities
- Recovery support interest during heavy training or illness recovery periods
- Mitochondrial function interest in longevity discussions
Most commonly reported downsides
- Injection-site irritation or discomfort
- Nausea
- Headache
- Fatigue
Rare but important symptoms to watch for
These are uncommon, but if they occur, stop and seek medical care.
- Allergic reaction with hives, facial swelling, or trouble breathing
- Severe dizziness, fainting, or chest pain
- Severe swelling, rapidly spreading redness, or drainage at an injection site
Who should be cautious
- Pregnancy or breastfeeding
- Children and adolescents
- Significant cardiovascular disease
- Significant kidney or liver disease
Interactions summarize known or plausible ways this peptide may intersect with medications, supplements, or physiologic states. Use this as a risk-awareness map: what to ask about, what to watch for, and what deserves a clinician conversation.